Click for best price
Lung Cancer Liquid Biopsy Market Size, Share 2022
Lung cancer liquid biopsy helps to detect the epidermal growth factor receptor (EGFR) mutation and other identified mutations, which are responsible for lung cancer.
This report contains market size and forecasts of Lung Cancer Liquid Biopsy in Global, including the following market information:
The global Lung Cancer Liquid Biopsy market was valued at 438 million in 2021 and is projected to reach US$ 1056.2 million by 2028, at a CAGR of 13.4% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
CTCs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Lung Cancer Liquid Biopsy include Biocept, Exosome Diagnostics, F. Hoffmann-La Roche, Qiagen, Accuragen, Agena Bioscience, Bard1 and Bgi, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Lung Cancer Liquid Biopsy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Lung Cancer Liquid Biopsy Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Lung Cancer Liquid Biopsy Market Segment Percentages, by Type, 2021 (%)
- CTCs
- CtDNA
- Exosomes And RNA
- Others
Global Lung Cancer Liquid Biopsy Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Lung Cancer Liquid Biopsy Market Segment Percentages, by Application, 2021 (%)
- Clinics
- Hospitals
- Physicians' Office Laboratories
Global Lung Cancer Liquid Biopsy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Lung Cancer Liquid Biopsy Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Lung Cancer Liquid Biopsy revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Lung Cancer Liquid Biopsy revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Biocept
- Exosome Diagnostics
- F. Hoffmann-La Roche
- Qiagen
- Accuragen
- Agena Bioscience
- Bard1
- Bgi
| Report Attributes |
Report Details |
| Report Title |
Lung Cancer Liquid Biopsy Market - Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
67 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Lung Cancer Liquid Biopsy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Lung Cancer Liquid Biopsy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Lung Cancer Liquid Biopsy Overall Market Size
2.1 Global Lung Cancer Liquid Biopsy Market Size: 2021 VS 2028
2.2 Global Lung Cancer Liquid Biopsy Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Lung Cancer Liquid Biopsy Players in Global Market
3.2 Top Global Lung Cancer Liquid Biopsy Companies Ranked by Revenue
3.3 Global Lung Cancer Liquid Biopsy Revenue by Companies
3.4 Top 3 and Top 5 Lung Cancer Liquid Biopsy Companies in Global Market, by Revenue in 2021
3.5 Global Companies Lung Cancer Liquid Biopsy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Lung Cancer Liquid Biopsy Players in Global Market
3.6.1 List of Global Tier 1 Lung Cancer Liquid Biopsy Companies
3.6.2 List of Global Tier 2 and Tier 3 Lung Cancer Liquid Biopsy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Lung Cancer Liquid Biopsy Market Size Markets, 2021 & 2028
4.1.2 CTCs
4.1.3 CtDNA
4.1.4 Exosomes And RNA
4.1.5 Others
4.2 By Type - Global Lung Cancer Liquid Biopsy Revenue & Forecasts
4.2.1 By Type - Global Lung Cancer Liquid Biopsy Revenue, 2017-2022
4.2.2 By Type - Global Lung Cancer Liquid Biopsy Revenue, 2023-2028
4.2.3 By Type - Global Lung Cancer Liquid Biopsy Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Lung Cancer Liquid Biopsy Market Size, 2021 & 2028
5.1.2 Clinics
5.1.3 Hospitals
5.1.4 Physicians' Office Laboratories
5.2 By Application - Global Lung Cancer Liquid Biopsy Revenue & Forecasts
5.2.1 By Application - Global Lung Cancer Liquid Biopsy Revenue, 2017-2022
5.2.2 By Application - Global Lung Cancer Liquid Biopsy Revenue, 2023-2028
5.2.3 By Application - Global Lung Cancer Liquid Biopsy Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Lung Cancer Liquid Biopsy Market Size, 2021 & 2028
6.2 By Region - Global Lung Cancer Liquid Biopsy Revenue & Forecasts
6.2.1 By Region - Global Lung Cancer Liquid Biopsy Revenue, 2017-2022
6.2.2 By Region - Global Lung Cancer Liquid Biopsy Revenue, 2023-2028
6.2.3 By Region - Global Lung Cancer Liquid Biopsy Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Lung Cancer Liquid Biopsy Revenue, 2017-2028
6.3.2 US Lung Cancer Liquid Biopsy Market Size, 2017-2028
6.3.3 Canada Lung Cancer Liquid Biopsy Market Size, 2017-2028
6.3.4 Mexico Lung Cancer Liquid Biopsy Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Lung Cancer Liquid Biopsy Revenue, 2017-2028
6.4.2 Germany Lung Cancer Liquid Biopsy Market Size, 2017-2028
6.4.3 France Lung Cancer Liquid Biopsy Market Size, 2017-2028
6.4.4 U.K. Lung Cancer Liquid Biopsy Market Size, 2017-2028
6.4.5 Italy Lung Cancer Liquid Biopsy Market Size, 2017-2028
6.4.6 Russia Lung Cancer Liquid Biopsy Market Size, 2017-2028
6.4.7 Nordic Countries Lung Cancer Liquid Biopsy Market Size, 2017-2028
6.4.8 Benelux Lung Cancer Liquid Biopsy Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Lung Cancer Liquid Biopsy Revenue, 2017-2028
6.5.2 China Lung Cancer Liquid Biopsy Market Size, 2017-2028
6.5.3 Japan Lung Cancer Liquid Biopsy Market Size, 2017-2028
6.5.4 South Korea Lung Cancer Liquid Biopsy Market Size, 2017-2028
6.5.5 Southeast Asia Lung Cancer Liquid Biopsy Market Size, 2017-2028
6.5.6 India Lung Cancer Liquid Biopsy Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Lung Cancer Liquid Biopsy Revenue, 2017-2028
6.6.2 Brazil Lung Cancer Liquid Biopsy Market Size, 2017-2028
6.6.3 Argentina Lung Cancer Liquid Biopsy Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Lung Cancer Liquid Biopsy Revenue, 2017-2028
6.7.2 Turkey Lung Cancer Liquid Biopsy Market Size, 2017-2028
6.7.3 Israel Lung Cancer Liquid Biopsy Market Size, 2017-2028
6.7.4 Saudi Arabia Lung Cancer Liquid Biopsy Market Size, 2017-2028
6.7.5 UAE Lung Cancer Liquid Biopsy Market Size, 2017-2028
7 Players Profiles
7.1 Biocept
7.1.1 Biocept Corporate Summary
7.1.2 Biocept Business Overview
7.1.3 Biocept Lung Cancer Liquid Biopsy Major Product Offerings
7.1.4 Biocept Lung Cancer Liquid Biopsy Revenue in Global Market (2017-2022)
7.1.5 Biocept Key News
7.2 Exosome Diagnostics
7.2.1 Exosome Diagnostics Corporate Summary
7.2.2 Exosome Diagnostics Business Overview
7.2.3 Exosome Diagnostics Lung Cancer Liquid Biopsy Major Product Offerings
7.2.4 Exosome Diagnostics Lung Cancer Liquid Biopsy Revenue in Global Market (2017-2022)
7.2.5 Exosome Diagnostics Key News
7.3 F. Hoffmann-La Roche
7.3.1 F. Hoffmann-La Roche Corporate Summary
7.3.2 F. Hoffmann-La Roche Business Overview
7.3.3 F. Hoffmann-La Roche Lung Cancer Liquid Biopsy Major Product Offerings
7.3.4 F. Hoffmann-La Roche Lung Cancer Liquid Biopsy Revenue in Global Market (2017-2022)
7.3.5 F. Hoffmann-La Roche Key News
7.4 Qiagen
7.4.1 Qiagen Corporate Summary
7.4.2 Qiagen Business Overview
7.4.3 Qiagen Lung Cancer Liquid Biopsy Major Product Offerings
7.4.4 Qiagen Lung Cancer Liquid Biopsy Revenue in Global Market (2017-2022)
7.4.5 Qiagen Key News
7.5 Accuragen
7.5.1 Accuragen Corporate Summary
7.5.2 Accuragen Business Overview
7.5.3 Accuragen Lung Cancer Liquid Biopsy Major Product Offerings
7.5.4 Accuragen Lung Cancer Liquid Biopsy Revenue in Global Market (2017-2022)
7.5.5 Accuragen Key News
7.6 Agena Bioscience
7.6.1 Agena Bioscience Corporate Summary
7.6.2 Agena Bioscience Business Overview
7.6.3 Agena Bioscience Lung Cancer Liquid Biopsy Major Product Offerings
7.6.4 Agena Bioscience Lung Cancer Liquid Biopsy Revenue in Global Market (2017-2022)
7.6.5 Agena Bioscience Key News
7.7 Bard1
7.7.1 Bard1 Corporate Summary
7.7.2 Bard1 Business Overview
7.7.3 Bard1 Lung Cancer Liquid Biopsy Major Product Offerings
7.7.4 Bard1 Lung Cancer Liquid Biopsy Revenue in Global Market (2017-2022)
7.7.5 Bard1 Key News
7.8 Bgi
7.8.1 Bgi Corporate Summary
7.8.2 Bgi Business Overview
7.8.3 Bgi Lung Cancer Liquid Biopsy Major Product Offerings
7.8.4 Bgi Lung Cancer Liquid Biopsy Revenue in Global Market (2017-2022)
7.8.5 Bgi Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Lung Cancer Liquid Biopsy Market Opportunities & Trends in Global Market
Table 2. Lung Cancer Liquid Biopsy Market Drivers in Global Market
Table 3. Lung Cancer Liquid Biopsy Market Restraints in Global Market
Table 4. Key Players of Lung Cancer Liquid Biopsy in Global Market
Table 5. Top Lung Cancer Liquid Biopsy Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Lung Cancer Liquid Biopsy Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Lung Cancer Liquid Biopsy Revenue Share by Companies, 2017-2022
Table 8. Global Companies Lung Cancer Liquid Biopsy Product Type
Table 9. List of Global Tier 1 Lung Cancer Liquid Biopsy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Lung Cancer Liquid Biopsy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Lung Cancer Liquid Biopsy Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Lung Cancer Liquid Biopsy Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Lung Cancer Liquid Biopsy Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Lung Cancer Liquid Biopsy Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Lung Cancer Liquid Biopsy Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Lung Cancer Liquid Biopsy Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Lung Cancer Liquid Biopsy Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Lung Cancer Liquid Biopsy Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Lung Cancer Liquid Biopsy Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Lung Cancer Liquid Biopsy Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Lung Cancer Liquid Biopsy Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Lung Cancer Liquid Biopsy Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Lung Cancer Liquid Biopsy Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Lung Cancer Liquid Biopsy Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Lung Cancer Liquid Biopsy Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Lung Cancer Liquid Biopsy Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Lung Cancer Liquid Biopsy Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Lung Cancer Liquid Biopsy Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Lung Cancer Liquid Biopsy Revenue, (US$, Mn), 2023-2028
Table 30. Biocept Corporate Summary
Table 31. Biocept Lung Cancer Liquid Biopsy Product Offerings
Table 32. Biocept Lung Cancer Liquid Biopsy Revenue (US$, Mn), (2017-2022)
Table 33. Exosome Diagnostics Corporate Summary
Table 34. Exosome Diagnostics Lung Cancer Liquid Biopsy Product Offerings
Table 35. Exosome Diagnostics Lung Cancer Liquid Biopsy Revenue (US$, Mn), (2017-2022)
Table 36. F. Hoffmann-La Roche Corporate Summary
Table 37. F. Hoffmann-La Roche Lung Cancer Liquid Biopsy Product Offerings
Table 38. F. Hoffmann-La Roche Lung Cancer Liquid Biopsy Revenue (US$, Mn), (2017-2022)
Table 39. Qiagen Corporate Summary
Table 40. Qiagen Lung Cancer Liquid Biopsy Product Offerings
Table 41. Qiagen Lung Cancer Liquid Biopsy Revenue (US$, Mn), (2017-2022)
Table 42. Accuragen Corporate Summary
Table 43. Accuragen Lung Cancer Liquid Biopsy Product Offerings
Table 44. Accuragen Lung Cancer Liquid Biopsy Revenue (US$, Mn), (2017-2022)
Table 45. Agena Bioscience Corporate Summary
Table 46. Agena Bioscience Lung Cancer Liquid Biopsy Product Offerings
Table 47. Agena Bioscience Lung Cancer Liquid Biopsy Revenue (US$, Mn), (2017-2022)
Table 48. Bard1 Corporate Summary
Table 49. Bard1 Lung Cancer Liquid Biopsy Product Offerings
Table 50. Bard1 Lung Cancer Liquid Biopsy Revenue (US$, Mn), (2017-2022)
Table 51. Bgi Corporate Summary
Table 52. Bgi Lung Cancer Liquid Biopsy Product Offerings
Table 53. Bgi Lung Cancer Liquid Biopsy Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Lung Cancer Liquid Biopsy Segment by Type in 2021
Figure 2. Lung Cancer Liquid Biopsy Segment by Application in 2021
Figure 3. Global Lung Cancer Liquid Biopsy Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Lung Cancer Liquid Biopsy Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Lung Cancer Liquid Biopsy Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Lung Cancer Liquid Biopsy Revenue in 2021
Figure 8. By Type - Global Lung Cancer Liquid Biopsy Revenue Market Share, 2017-2028
Figure 9. By Application - Global Lung Cancer Liquid Biopsy Revenue Market Share, 2017-2028
Figure 10. By Region - Global Lung Cancer Liquid Biopsy Revenue Market Share, 2017-2028
Figure 11. By Country - North America Lung Cancer Liquid Biopsy Revenue Market Share, 2017-2028
Figure 12. US Lung Cancer Liquid Biopsy Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Lung Cancer Liquid Biopsy Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Lung Cancer Liquid Biopsy Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Lung Cancer Liquid Biopsy Revenue Market Share, 2017-2028
Figure 16. Germany Lung Cancer Liquid Biopsy Revenue, (US$, Mn), 2017-2028
Figure 17. France Lung Cancer Liquid Biopsy Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Lung Cancer Liquid Biopsy Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Lung Cancer Liquid Biopsy Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Lung Cancer Liquid Biopsy Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Lung Cancer Liquid Biopsy Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Lung Cancer Liquid Biopsy Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Lung Cancer Liquid Biopsy Revenue Market Share, 2017-2028
Figure 24. China Lung Cancer Liquid Biopsy Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Lung Cancer Liquid Biopsy Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Lung Cancer Liquid Biopsy Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Lung Cancer Liquid Biopsy Revenue, (US$, Mn), 2017-2028
Figure 28. India Lung Cancer Liquid Biopsy Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Lung Cancer Liquid Biopsy Revenue Market Share, 2017-2028
Figure 30. Brazil Lung Cancer Liquid Biopsy Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Lung Cancer Liquid Biopsy Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Lung Cancer Liquid Biopsy Revenue Market Share, 2017-2028
Figure 33. Turkey Lung Cancer Liquid Biopsy Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Lung Cancer Liquid Biopsy Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Lung Cancer Liquid Biopsy Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Lung Cancer Liquid Biopsy Revenue, (US$, Mn), 2017-2028
Figure 37. Biocept Lung Cancer Liquid Biopsy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Exosome Diagnostics Lung Cancer Liquid Biopsy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. F. Hoffmann-La Roche Lung Cancer Liquid Biopsy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Qiagen Lung Cancer Liquid Biopsy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Accuragen Lung Cancer Liquid Biopsy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Agena Bioscience Lung Cancer Liquid Biopsy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Bard1 Lung Cancer Liquid Biopsy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Bgi Lung Cancer Liquid Biopsy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
